CINCINNATI, Dec. 9 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL) a leading, global full-service clinical research organization, today announced President Simon Higginbotham will participate in the annual Raymond James Boston Fall Investors Conference. The conference will be held at The State Room, 60 State Street, 33rd floor, in Boston on Dec. 11, 2008. Kendle's presentation is scheduled from 2:30 to 3:15 p.m. Eastern Standard Time.
Presentations will not be webcast at the conference. However, slides from Kendle's presentation will be available by 11 a.m. Eastern Standard Time on Dec. 11 at http://www.kendle.com under the Investor Events and Presentations section.
Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the fastest-growing global providers of Phase I-IV services, we offer experience spanning 90 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.
Kendle was recognized by FORTUNE magazine as one of the 100 fastest-growing companies in the United States for 2008. The company also has been recognized as "Top CRO to Work With" in the CenterWatch 2007 survey of U.S. investigative sites and "Best CRO" for 2007 and 2006 by leading global pharmaceutical publication Scrip World Pharmaceutical News.
Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the Company's Web site at http://www.kendle.com .
|SOURCE Kendle International Inc.|
Copyright©2008 PR Newswire.
All rights reserved